an advanced cell technology blog

ACT's Company Blog.

Advanced Cell Technology, Inc. (OTCBB: ACTC) is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit www.advancedcell.com.

  • Company Blog
  • ACTC.OBTerms of use
  • Contact

These are the posts from March 2011

March 23, 2011
Posted by admin

ACT to Be Issued Broad Patent for Human ES Cell-derived RPE Cells in China

The Company issued the following announcement this morning.
ACT to Be Issued Broad Patent for Human ES Cell-derived RPE Cells in China
Chinese Patent to Cover Fundamental Methods for Producing Retinal Pigment Epithelial (RPE) Cells from Embryonic Stem Cells and Therapeutic Formulations for Treating Patients with Retinal Degenerative Diseases
MARLBOROUGH, Mass. – March 23, 2011 – Advanced Cell [...]

No Comments

Posted Under Uncategorized

March 21, 2011
Posted by admin

Advanced Cell Technology Announces 2010 Results

ACT made the following announcement this morning.
Advanced Cell Technology Announces 2010 Results
• Company Ends Year with $15.9 Million in Cash and Less Than $1 Million of Debt
• Company Eliminates $20 Million of Indebtedness and Liabilities in 2010 Fourth Quarter
• Receives Unqualified Audit Opinion
Company To Host Conference Call at 9 am EDT Today
MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, [...]

No Comments

Posted Under Uncategorized

March 10, 2011
Posted by admin

ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardt’s Disease

ACT made the following major announcement this morning.
MARLBOROUGH, Mass. – March 10, 2011 – Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC), a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT’s human embryonic stem cell [...]

No Comments

Posted Under Uncategorized


     

    ACT Publishes...

    Uncategorized

      

    Scientific...

    Uncategorized

      

    ACT and Roslin...

    Uncategorized

    Gary Rabin Chairman's Blog: Timing and Pace of Our Clinical Trials http://t.co/I6YfXPDc #SMD #DryAMD #hESCs

    follow me on
    twitter

    ACTC.OB Stock Quote


    Advanced Cell Tecchart +0.00%

    2012-02-22 15:59

  • Categories

    • ACT Events
    • Biotechnology
      • Regenerative
    • human trials
    • Stock Talk
      • Governance
      • Reports
    • Uncategorized

  • Archives

    • 2012
      • January
    • 2011
      • January
      • February
      • March
      • April
      • May
      • June
      • October
    • 2010
      • January
      • February
      • March
      • April
      • May
      • June
      • July
      • August
      • September
      • November
      • December

    • Facebook

    ACT Links

    • Biotech Investors Network
    • Medical Technology
    • Patient Support Group
    • LinkedIn Company page
    • Facebook Company page
    • Twitter Company page
    • Google Groups
    • Chairmans blog RSS feed

Powered by WordPress: this website is official and sanctioned by Advanced Cell Technology.